Publication | Open Access
One-year experience with implanon sub-dermal implants in Jos, Nigeria
16
Citations
0
References
2010
Year
Contraceptive UseHormonal ContraceptiveFertilityOral ContraceptiveReproductive HealthContraceptive DiscontinuationGynecologyImplanon Sub-dermal ImplantsDermatologyFamily PlanningContraceptionContraceptive ImplantsReproductive MedicineImplanon AcceptancePublic HealthProsthesisSexual And Reproductive HealthInitial Experiencewith ThemethodImplanon CapsulesImplantable DeviceImplantologyContraceptive UptakeWound HealingMedicinePlastic SurgeryDermatological SurgeryWomen's Health
To determine Implanon acceptance, the group of women accepting it, complications, indications for discontinuation; and report an initial experiencewith themethod. Thiswas a retrospective observational study of Implanon®, a single rod, long acting, reversible subdermal contraceptive implant system, containing the progestin etonogestrel, which was introduced in Jos, Nigeria, inMay 2006. Implanon capsules were accepted by 404 clients constituting 13.4% of acceptors of all contraceptive methods. The average age, parity and number of living children to the acceptors were 32.1 years, 3.6 and 3.3 respectively.About three-quarters (76.0%) of the women had secondary and tertiary education. Seventy-three (18.1%) of the women were taking a modern contraceptive method for the first time. There were 7 removals giving a high continuation rate of 98.3% in the first year. Menstrual disturbance was the commonest (57.1%) indication for removal. Implanon is an acceptablemethod of contraception among ourwomen population. Keywords: Implant, Implanon, sub-dermal, Jos,Nigeria.